Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
91.2M
-
Shares change
-
-883K
-
Total reported value, excl. options
-
$1.96B
-
Value change
-
-$31.8M
-
Put/Call ratio
-
0.97
-
Number of buys
-
93
-
Number of sells
-
-73
-
Price
-
$21.53
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2024
217 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q2 2024.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.2M shares
of 107M outstanding shares and own 85.07% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (17.7M shares), WELLINGTON MANAGEMENT GROUP LLP (9.16M shares), BlackRock Inc. (6.19M shares), VANGUARD GROUP INC (5.81M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4.33M shares), MAVERICK CAPITAL LTD (3.93M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.17M shares), JANUS HENDERSON GROUP PLC (2.92M shares), CITADEL ADVISORS LLC (2.82M shares), and STATE STREET CORP (2.78M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.